Cargando…
Molecular Determinants of Cancer Therapy Resistance to HDAC Inhibitor-Induced Autophagy
Histone deacetylation inhibitors (HDACi) offer high potential for future cancer therapy as they can re-establish the expression of epigenetically silenced cell death programs. HDACi-induced autophagy offers the possibility to counteract the frequently present apoptosis-resistance as well as stress c...
Autores principales: | Mrakovcic, Maria, Fröhlich, Leopold F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016854/ https://www.ncbi.nlm.nih.gov/pubmed/31906235 http://dx.doi.org/10.3390/cancers12010109 |
Ejemplares similares
-
p53 at the Crossroads between Different Types of HDAC Inhibitor-Mediated Cancer Cell Death
por: Mrakovcic, Maria, et al.
Publicado: (2019) -
Epigenetic Targeting of Autophagy via HDAC Inhibition in Tumor Cells: Role of p53
por: Mrakovcic, Maria, et al.
Publicado: (2018) -
Histone Deacetylase Inhibitor-Induced Autophagy in Tumor Cells: Implications for p53
por: Mrakovcic, Maria, et al.
Publicado: (2017) -
p53-Mediated Molecular Control of Autophagy in Tumor Cells
por: Mrakovcic, Maria, et al.
Publicado: (2018) -
Molecular mechanism leading to SAHA-induced autophagy in tumor cells: evidence for a p53-dependent pathway
por: Fröhlich, Leopold F., et al.
Publicado: (2016)